Page last updated: 2024-12-11

nifurzide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nifurzide: structure given in first source & in Negwer, 5th ed, #6261 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9571044
CHEMBL ID2106530
CHEBI ID135428
SCHEMBL ID467248
SCHEMBL ID467247
MeSH IDM0095082

Synonyms (31)

Synonym
nifurzide
ricridene
39978-42-2
D07251
nifurzide (inn)
ricridene (tn)
5-nitro-n'-(3-(5-nitro-2-furyl)allyliden)-2-thiophencarbohydrazid
einecs 254-728-0
nifurzida [inn-spanish]
nifurzide [inn]
nifurzidum [inn-latin]
2-thiophenecarboxylic acid, 5-nitro-, (3-(5-nitro-2-furanyl)-2-propenylidene)hydrazide
brn 1331076
5-nitro-2-thiophenecarboxylic acid (3-(5-nitro-2-furanyl)-2-propenylidine)hydrazide
n(sup 1)-(5'-nitro-2'-thenoyl)-n(sup 2)-(5''-nitro-2''-furylacryliden) hydrazin [german]
5-nitro-2-thiophenecarboxylic acid (3-(5-nitro-2-furyl)allylidene)hydrazide
CHEBI:135428
n(sup 1)-(5'-nitro-2'-thenoyl)-n(sup 2)-(5''-nitro-2''-furylacryliden) hydrazin
z35r6k4c26 ,
unii-z35r6k4c26
nifurzida
nifurzidum
CHEMBL2106530
nifurzide [mi]
2-thiophenecarboxylic acid, 5-nitro-, 2-(3-(5-nitro-2-furanyl)-2-propen-1-ylidene)hydrazide
nifurzide [who-dd]
nifurzide [mart.]
SCHEMBL467248
SCHEMBL467247
DB13325
AKOS040747209

Research Excerpts

Overview

Nifurzide is a nitrofuran with antibacterial activity.

ExcerptReferenceRelevance
"Nifurzide is a nitrofuran with antibacterial activity. "( Inhibition of conjugal transfer of R plasmids by nitrofurans.
Laporte, JM; Michel-Briand, Y, 1985
)
1.71
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
thiophenesCompounds containing at least one thiophene ring.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.79 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]